Studies using mouse models of cancer with EC-specific deletion of HIF2-alpha have also shown reduced tumor growth rates compared with wild type mice [10], but the effect of EC-specific HIF2-alpha deletion on metastatic efficiency in these mice has been reported as being advantageous [10] and deleterious [11]. This evidence concerns the gene EPAS1 and cancer.